The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001
Open accessAbstract
Object: An increasing incidence of brain cancer has been reported for the last three decades. In this study of brain cancer incidence and patient survival in the US, the authors attempt to update information on trends by examining data provided by the Surveillance, Epidemiology, and End Results (SEER) Program. Methods: Population-based data from the SEER Program were used to calculate the incidence of and survival rates for people with brain cancer. The approximate Poisson method was used to calculate relative risks for brain cancer and to determine a 95% confidence interval. Annual age-standardized incidence rates were calculated, and time-trend analysis was conducted using joinpoint regression analysis. The relative risks of brain cancer were 1.48 for men compared with women, 3.18 for elderly persons compared with young adults, 1.86 for Caucasian patients compared with African-American patients, and 1.35 for those in metropolitan counties compared with those in nonmetropolitan counties. The incidence of brain cancer increased until 1987, when the annual percentage of change reversed direction, decreasing from 1.68 to −0.44%. The elderly experienced an increase until 1985, but their rates were stable thereafter. Rising trends were noticed for glioblastoma multiforme (GBM), oligodendroglioma, anaplastic astrocytoma, medulloblastoma, and mixed glioma, and falling trends were observed for astrocytoma not otherwise specified and malignant glioma. The survival rate for patients with GBM has not shown improvement in the last two decades. Conclusions: Increased risk of brain cancer is associated with being male, Caucasian, elderly, and residing in a metropolitan county. The incidence rate of brain cancer in the US is gradually declining, but the rising trend of GBM combined with its poor survival rate is disconcerting and needs further exploration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular-Telephone Use and Brain Tumors
Inskip, P. D., Tarone, R. E., Hatch, E. E., Wilcosky, T. C., Shapiro, W. R., Selker, R. G., Fine, H. A., Black, P. M., Loeffler, J. S., & Linet, M. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440201 · Cited by 483
Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality
Legler, J. M., Ries, L. A. G., Smith, M. A., Warren, J. L., Heineman, E. F., Kaplan, R. S., & Linet, M. S. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.16.1382 · Cited by 452
Surawicz, T. S., McCarthy, B. J., Kupelian, V. A., Jukich, P. J., Bruner, J. M., & Davis, F. G. (1999) · Neuro-Oncology · doi:10.1093/neuonc/1.1.14 · Cited by 443
Handheld Cellular Telephone Use and Risk of Brain Cancer
Muscat, J. E. (2000) · JAMA · doi:10.1001/jama.284.23.3001 · Cited by 310
Brain and other central nervous system tumors: rates, trends, and epidemiology
Gurney, J. G., & Kadan-Lottick, N. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200105000-00005 · Cited by 175
MOBILE TELEPHONES AND CANCER—A REVIEW OF EPIDEMIOLOGICAL EVIDENCE
Kundi, M., Mild, K. H., Hardell, L., & Mattsson, M.-O. (2004) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400490486258 · Cited by 161
The impact of age and gender on the incidence of glial tumors in New York state from 1976–1995
McKinley, B., Michalek, A. M., Fenstermaker, R. A., & Plunkett, R. J. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.93.6.0932 · Cited by 132
Heshmat, M. Y., Kovi, J., Simpson, C., Kennedy, J. A., & Fan, K.-J. (1976) · Cancer · Cited by 73
The incidence of primary CNS neoplasms before and after computerized tomography availability
Helseth, A. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.83.6.0999 · Cited by 72
The glioblastoma multiforme in Georgia, 1977–1981
McLendon, R. E., Robinson, J. S., Chambers, D. B., Grufferman, S., & Burger, P. C. (1985) · Cancer · Cited by 46
Cited by
Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3090 · Cited by 940
Glioblastoma survival in the United States before and during the temozolomide era
Johnson, D. R., & O’Neill, B. P. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0749-4 · Cited by 720
A Review on a Deep Learning Perspective in Brain Cancer Classification
Tandel, G. S., Biswas, M., Kakde, O. G., Tiwari, A., Suri, H. S., Turk, M., Laird, J., Asare, C., Ankrah, A. A., Khanna, N. N., et al. (2019) · Cancers · doi:10.3390/cancers11010111 · Cited by 466
Bloch, O., Crane, C. A., Kaur, R., Safaee, M., Rutkowski, M. J., & Parsa, A. T. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3314 · Cited by 458
Prins, R. M., Soto, H., Konkankit, V., Odesa, S. K., Eskin, A., Yong, W. H., Nelson, S. F., & Liau, L. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2563 · Cited by 451
Impact of extent of resection for recurrent glioblastoma on overall survival: Clinical article
Bloch, O., Han, S. J., Cha, S., Sun, M. Z., Aghi, M. K., McDermott, M. W., Berger, M. S., & Parsa, A. T. (2012) · Journal of Neurosurgery · doi:10.3171/2012.9.jns12504 · Cited by 432
Porter, K. R., McCarthy, B. J., Freels, S., Kim, Y., & Davis, F. G. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop066 · Cited by 342
US FDA Breast Implant Postapproval Studies: Long-term Outcomes in 99,993 Patients
Coroneos, C. J., Selber, J. C., Offodile, A. C., Butler, C. E., & Clemens, M. W. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000002990 · Cited by 302
Racial, ethnic and socioeconomic disparities in the treatment of brain tumors
Curry, W. T., & Barker, F. G. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9840-5 · Cited by 152
Metadata
- Authors
- Deorah, S., Lynch, C. F., Sibenaller, Z. A., & Ryken, T. C.
- Venue
- Neurosurgical Focus
- Published
- 2006-04
- Volume
- 20
- Issue
- 4
- Pages
- E1
- ISSN
- 1092-0684 (ISSN-L)
- OpenAlex
- W2157075165
- Cited by
- 347
- References
- 11
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.